| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | -1,100 | -7.16%14,272 | $151.48 | $166,628 | View SEC filing | |
| 2026-06-03 | Polen Thomas E Jr Chairman, CEO and President | Sale | -2,764 | -2.45%110,163 | $146.35 | $404,511 | View SEC filing | |
| 2026-05-27 | Feld Michael EVP, Chief Revenue Officer | Sale | -75 | -0.35%21,084 | $147.35 | $11,051 | View SEC filing | |
| 2026-04-27 | Feld Michael EVP, Chief Revenue Officer | Sale | -74 | -0.35%21,159 | $151.94 | $11,244 | View SEC filing | |
| 2026-03-27 | Feld Michael EVP, Chief Revenue Officer | Sale | -75 | -0.35%21,233 | $156.83 | $11,762 | View SEC filing | |
| 2026-02-27 | Feld Michael EVP, Chief Revenue Officer | Sale | -75 | -0.35%21,308 | $181.84 | $13,638 | View SEC filing | |
| 2026-02-18 | SCOTT BERTRAM L Director | Sale | -953 | -2.53%36,763 | $182.61 | $174,027 | View SEC filing | |
| 2026-01-28 | Feld Michael EVP, CRO & Pres. Life Sciences | Sale | -75 | -0.45%16,431 | $202.73 | $15,205 | View SEC filing | |
| 2026-01-16 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | -1,610 | -11.75%12,095 | $207.46 | $334,005 | View SEC filing | |
| 2025-12-29 | Feld Michael EVP, CRO & Pres. Life Sciences | Sale | -74 | -0.45%16,506 | $196.08 | $14,510 | View SEC filing | |
| 2025-12-17 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | -629 | -4.58%13,105 | $196.03 | $123,303 | View SEC filing | |
| 2025-12-02 | Feld Michael EVP, CRO & Pres. Life Sciences | Sale | -75 | -0.45%16,580 | $193.36 | $14,502 | View SEC filing | |
| 2025-11-07 | SCOTT BERTRAM L Director | Sale | -217 | -0.60%35,816 | $176.58 | $38,318 | View SEC filing | |
| 2025-10-28 | Feld Michael EVP & President, Life Sciences | Sale | -57 | -0.69%8,245 | $186.01 | $10,603 | View SEC filing | |
| 2025-09-29 | Feld Michael EVP & President, Life Sciences | Sale | -58 | -0.69%8,302 | $181.03 | $10,500 | View SEC filing | |
| 2025-09-11 | Fraser Claire Director | Sale | -917 | -3.96%22,226 | $187.50 | $171,938 | View SEC filing | |
| 2025-08-26 | Feld Michael EVP & President, Life Sciences | Sale | -57 | -0.68%8,360 | $197.99 | $11,285 | View SEC filing | |
| 2025-08-11 | HAYES GREGORY Director | Purchase | +5,250 | +659.55%6,046 | $191.57 | $1,005,743 | View SEC filing | |
| 2025-08-08 | Fraser Claire Director | Sale | -863 | -3.59%23,143 | $192.30 | $165,955 | View SEC filing | |
| 2025-07-22 | Garrison Michael David EVP & President, Medical | Sale | -1,185 | -19.52%4,887 | $180.29 | $213,645 | View SEC filing | |
| 2025-06-02 | Shan David EVP and Chief ISC Officer | Sale | -1,166 | -20.31%4,575 | $171.19 | $199,608 | View SEC filing | |
| 2025-04-10 | Garrison Michael David EVP & President, Medical | Sale | -479 | -8.93%4,887 | $197.28 | $94,497 | View SEC filing | |
| 2025-03-19 | Byrd Richard EVP & President Interventional | Sale | -459 | -6.19%6,952 | $230.00 | $105,570 | View SEC filing | |
| 2025-03-13 | Byrd Richard EVP & President Interventional | Sale | -1,940 | -20.75%7,411 | $224.91 | $436,325 | View SEC filing | |
| 2025-02-12 | SCOTT BERTRAM L Director | Sale | -700 | -1.91%36,033 | $227.99 | $159,593 | View SEC filing |
1-25 of 395
